BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 53 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $592,301 | +96209.1% | 15,129 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $615 | -2.8% | 15,129 | 0.0% | 0.02% | -10.0% |
| Q1 2023 | $633 | -3.9% | 15,129 | 0.0% | 0.02% | -9.1% |
| Q4 2022 | $659 | -99.9% | 15,129 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $587,000 | +9.1% | 15,129 | +19.2% | 0.02% | +15.8% |
| Q2 2022 | $538,000 | -6.9% | 12,695 | 0.0% | 0.02% | +5.6% |
| Q1 2022 | $578,000 | +26.2% | 12,695 | +34.3% | 0.02% | +28.6% |
| Q4 2021 | $458,000 | +1.8% | 9,450 | 0.0% | 0.01% | -6.7% |
| Q3 2021 | $450,000 | -1.7% | 9,450 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $458,000 | +4.8% | 9,450 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $437,000 | -2.9% | 9,450 | 0.0% | 0.02% | -11.8% |
| Q4 2020 | $450,000 | +53.1% | 9,450 | +38.0% | 0.02% | +30.8% |
| Q3 2020 | $294,000 | +10.1% | 6,850 | +4.6% | 0.01% | 0.0% |
| Q2 2020 | $267,000 | – | 6,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nova R Wealth, Inc. | 455,058 | $19,048,715 | 12.88% |
| Alterity Financial Group, LLC | 12,286 | $514,309 | 0.75% |
| Cornerstone Advisory, LLC | 85,260 | $3,568,968 | 0.64% |
| Owen LaRue, LLC | 12,912 | $557,156 | 0.60% |
| Semus Wealth Partners LLC | 13,170 | $551,296 | 0.59% |
| PRIMORIS WEALTH ADVISORS, LLC | 7,984 | $334,194 | 0.41% |
| CORRADO ADVISORS, LLC | 9,285 | $388,671 | 0.26% |
| Founders Financial Alliance, LLC | 10,612 | $444,336 | 0.22% |
| Diversified, LLC | 12,870 | $538,733 | 0.19% |
| Waterfront Wealth Inc. | 7,744 | $324,178 | 0.11% |